Midday’s Tom Hall talks with Dr. Jeffrey Kahn about clinical trials and diversity. Why is so much medical research still done with white subjects — and more often with men rather than women — and what are the consequences of that, particularly for women and people of color?

Quick Read

Two experimental trials bode well for gaining control of the hemorrhagic viral disease

Quick Read

There is an increasing body of evidence to suggest that significant quantities of medicines and medical products, especially in low and middle-income countries, are of poor quality. Malaria researcher and drug quality expert Professor Paul Newton, of the Lao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit in Laos, explains the latest research findings

Quick Read

Antiretroviral use before sex among men who have sex with men has shown early success. But “pre-exposure prophylaxis” raises ethical issues for current, future HIV prevention trials

Read More